Estrogen replacement therapy for postmenopausal osteoporosis.

In postmenopausal women, inevitable longitudinal loss of bone mass is increased in association with reduced levels of endogenous estrogen. A review of the health-care literature on therapy for postmenopausal osteoporosis provides strong evidence for prevention and treatment with estrogen/progestogen replacement therapy. This therapy was not associated with endometrial carcinoma.